Lonza primary, diseased primary and stem cells

Wednesday, 14 March, 2012 | Supplied by: Capsugel Australia Pty Ltd

Lonza primary, diseased primary and stem cells

Research shows that non-transformed, non-immortalised cells isolated directly from tissue provide conditions that closely simulate a living model and yield more physiologically significant results.

With Clonetics Primary Normal Cells and Media, Lonza provides over 150 authenticated primary human and animal cell types with optimised media for growth and maintenance.

With Clonetics Primary Diseased Cells, the company offers primary cells derived from patients with COPD, asthma, Type 1 and Type 2 diabetes.

The company’s Stem Cells and Media offer primary human adult stem and progenitor cells from bone marrow, cord blood and adipose tissue with growth and differentiation media, and ES-derived differentiated cells and media.

Lonza primary cells and media are tested together to guarantee performance. The company uses strict industry QC standards to ensure consistent performance on every lot manufactured.

All tissue utilised for the company’s human cell products is ethically obtained with documented and informed donor consent.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Antibodies Inc recombinant antibodies

Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.

Bioss Multiplex Fluorescent IHC Staining Kit

The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...

AdipoGen immune checkpoint reagents for immuno-oncology research

AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd